Esomeprazole/meloxicam - Axsome Therapeutics

Drug Profile

Esomeprazole/meloxicam - Axsome Therapeutics

Alternative Names: AXS 06

Latest Information Update: 14 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Axsome Therapeutics
  • Class 2 pyridinylmethylsulfinylbenzimidazoles; 2 ring heterocyclic compounds; Amides; Analgesics; Antipyretics; Antiulcers; Gastric antisecretories; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Small molecules; Thiazines; Thiazoles
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors; Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Pain

Most Recent Events

  • 14 Aug 2017 Chemical structure information added
  • 25 Jul 2017 Topline pharmacokinetics and adverse events data from a phase I trial in Pain (Healthy volunteers) released by Axsome Therapeutics
  • 25 Jul 2017 Axsome Therapeutics completes a phase I pharmacokinetics trial in Pain (Healthy volunteers) in USA (PO) before July 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top